EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹681 Cr | ₹498 Cr | ₹532 Cr | ₹662 Cr | ₹392 Cr |
What is the latest Consolidated Net Profit of EMCURE PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹681 Cr |
| Mar2024 | ₹498 Cr |
| Mar2023 | ₹532 Cr |
| Mar2022 | ₹662 Cr |
| Mar2021 | ₹392 Cr |
How is Consolidated Net Profit of EMCURE PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹681 Cr | 36.76 | |
| Mar2024 | ₹498 Cr | -6.36 | |
| Mar2023 | ₹532 Cr | -19.66 | |
| Mar2022 | ₹662 Cr | 68.87 | |
| Mar2021 | ₹392 Cr | - | |
Compare Consolidated Net Profit of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹33,839.6 Cr | -0.5% | 3.5% | 40.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.5% |
3.5% |
40.5% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses